An agonist of α4β2 and α6β2 subunit-containing nAChRs
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

5-iodo A-85380 (hydrochloride)

Item No. 43194

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
3-[(2S)-2-azetidinylmethoxy]-5-iodo-pyridine, dihydrochloride
CAS Number
1217837-17-6
Molecular Formula
C9H11IN2O • 2HCl
Formula Weight
363.0
Purity
≥98%
Formulation
A solid
Solubility(Learn about Variance in Solubility)
DMSO: Soluble: ≥ 10 mg/mlEthanol: Sparingly soluble: 1-10 mg/mlPBS (pH 7.2): Soluble: ≥ 10 mg/ml
SMILES
IC1=CC(OC[C@@H]2CCN2)=CN=C1.Cl.Cl
InChi Code
InChI=1S/C9H11IN2O.2ClH/c10-7-3-9(5-11-4-7)13-6-8-1-2-12-8;;/h3-5,8,12H,1-2,6H2;2*1H/t8-;;/m0../s1
InChi Key
ZJVVFYWEBSHGBV-JZGIKJSDSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    5 mg

    $83

    Add

    10 mg

    $149

    Add

    25 mg

    $290

    Add
    Product Description

    5-iodo A-85380 is an agonist of α4β2 and α6β2 subunit-containing nicotinic acetylcholine receptors (nAChRs).1 It activates α-conotoxin MII-sensitive and -insensitive dopamine release in rat striatal synaptosomes, markers of α4β2 and α6β2 subunit-containing nAChR activation, respectively (EC50s = 12.7 and ~35 nM, respectively). In vivo, 5-iodo A-85380 (0.37 µmol/kg per day) decreases the total number of abnormal involuntary movements (AIMs) in a rat model of L-DOPA-induced Parkinson’s disease.2

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Mogg, A.J., Jones, F.A., Pullar, I.A., et al. Functional responses and subunit composition of presynaptic nicotinic receptor subtypes explored using the novel agonist 5-iodo-A-85380. Neuropharmacology 47(6), 848-859 (2004).

    2. Huang, L.Z., Campos, C., Ly, J., et al. Nicotinic receptor agonists decrease L-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian rats. Neuropharmacology 60(6), 861-861 (2011).